| Trial ID: | L2142 |
| Source ID: | NCT00272831
|
| Associated Drug: |
Cilostazol
|
| Title: |
The Use of Cilostazol in Patients With Diabetic Nephropathy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Diabetes Complications
|
| Interventions: |
DRUG: Cilostazol|DRUG: Placebo
|
| Outcome Measures: |
Primary: Doubling of serum creatinine level, 1 year|50% reduction in GFR (estimated by MDRD equation), 1 year|GFR less than 15 ml/min/1.73m2, 1 year|Need for dialysis, 1 year|Death related to renal causes, 1 year|Fatal or severe bleeding, 1 year | Secondary: Composite cardiovascular endpoints (acute myocardial infarction, revascularisation procedures, heart failure or unstable angina or arrhythmia) requiring hospital admissions, lower extremity amputation), 1 year|Number of hospital admissions, total number of days of hospital stay and attendance at the Accident and Emergency Department, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Chinese University of Hong Kong
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
62
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-12
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2009-05-22
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00272831
|
